Report #2895382

Received May 5, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 17 yrs
State: WA
Recovered: Unknown
Vaccinated: Apr 24, 2026
Onset: Apr 24, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNP	MENINGOCOCCAL CONJUGATE (PENMENVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	5S723-5	—

Symptoms (1)

Product preparation issue

Symptom narrative

Penmenvy liquid portion only administration; Penmenvy liquid portion only administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 17-year-old female patient who received Men ABCWY NVS (Penmenvy) (batch number 5S723-5, expiry date 30-MAR-2028) for prophylaxis. On 24-APR-2026, the patient received Penmenvy. On 24-APR-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Penmenvy liquid portion only administration) and inappropriate dose of vaccine administered (Verbatim: Penmenvy liquid portion only administration). This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.